{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,12]],"date-time":"2026-07-12T05:14:16Z","timestamp":1783833256559,"version":"3.55.0"},"reference-count":56,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,4,1]],"date-time":"2018-04-01T00:00:00Z","timestamp":1522540800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,4,1]],"date-time":"2018-04-01T00:00:00Z","timestamp":1522540800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100007911","name":"University of California, San Diego","doi-asserted-by":"publisher","award":["UL1TR001442"],"award-info":[{"award-number":["UL1TR001442"]}],"id":[{"id":"10.13039\/100007911","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01 DE022757"],"award-info":[{"award-number":["R01 DE022757"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000738","name":"U.S. Department of Veterans Affairs","doi-asserted-by":"publisher","award":["5I01BX000638"],"award-info":[{"award-number":["5I01BX000638"]}],"id":[{"id":"10.13039\/100000738","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000890","name":"National Multiple Sclerosis Society","doi-asserted-by":"publisher","award":["PR-1503-03449"],"award-info":[{"award-number":["PR-1503-03449"]}],"id":[{"id":"10.13039\/100000890","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Immunological Methods"],"published-print":{"date-parts":[[2018,4]]},"DOI":"10.1016\/j.jim.2018.02.002","type":"journal-article","created":{"date-parts":[[2018,2,8]],"date-time":"2018-02-08T13:17:42Z","timestamp":1518095862000},"page":"80-87","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"special_numbering":"C","title":["A sensitive and selective ELISA methodology quantifies a demyelination marker in experimental and clinical samples"],"prefix":"10.1016","volume":"455","author":[{"given":"Albert G.","family":"Remacle","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Dolkas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mila","family":"Angert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Swathi K.","family":"Hullugundi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrei V.","family":"Chernov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"III","given":"R. Carter W.","family":"Jones","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Veronica I.","family":"Shubayev","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3765-3016","authenticated-orcid":false,"given":"Alex Y.","family":"Strongin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"Suppl. 2","key":"10.1016\/j.jim.2018.02.002_bb0005","doi-asserted-by":"crossref","first-page":"14593","DOI":"10.1073\/pnas.0404887101","article-title":"Mechanism of action of glatiramer acetate in multiple sclerosis and its potential for the development of new applications","volume":"101","author":"Arnon","year":"2004","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jim.2018.02.002_bb0010","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1212\/WNL.0b013e3182698dc3","article-title":"Autoimmune pain: an emerging concept","volume":"79","author":"Bennett","year":"2012","journal-title":"Neurology"},{"key":"10.1016\/j.jim.2018.02.002_bb0015","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.1007\/s00018-006-6094-7","article-title":"Myelin basic protein: a multifunctional protein","volume":"63","author":"Boggs","year":"2006","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.jim.2018.02.002_bb0020","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/0304-3940(95)12173-0","article-title":"Matrix metalloproteinases degrade myelin basic protein","volume":"201","author":"Chandler","year":"1995","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.jim.2018.02.002_bb0025","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1006\/bbrc.1996.1677","article-title":"Macrophage metalloelastase degrades matrix and myelin proteins and processes a tumour necrosis factor-alpha fusion protein","volume":"228","author":"Chandler","year":"1996","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.jim.2018.02.002_bb0030","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1002\/glia.20851","article-title":"MMP-9 controls Schwann cell proliferation and phenotypic remodeling via IGF-1 and ErbB receptor-mediated activation of MEK\/ERK pathway","volume":"57","author":"Chattopadhyay","year":"2009","journal-title":"Glia"},{"key":"10.1016\/j.jim.2018.02.002_bb0035","doi-asserted-by":"crossref","first-page":"11771","DOI":"10.1074\/jbc.M114.622316","article-title":"The calcium-binding proteins S100A8 and S100A9 initiate the early inflammatory program in injured peripheral nerves","volume":"290","author":"Chernov","year":"2015","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jim.2018.02.002_bb0040","first-page":"S104","article-title":"Misdiagnosis in fibromyalgia: a multicentre study","volume":"29","author":"Di Franco","year":"2011","journal-title":"Clin. Exp. Rheumatol."},{"key":"10.1016\/j.jim.2018.02.002_bb0045","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1097\/00002281-200303000-00002","article-title":"Environmental epidemiology and risk factors for autoimmune disease","volume":"15","author":"Dooley","year":"2003","journal-title":"Curr. Opin. Rheumatol."},{"key":"10.1016\/j.jim.2018.02.002_bb0050","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1007\/s11064-006-9116-9","article-title":"Differences in susceptibility of MBP charge isomers to digestion by stromelysin-1 (MMP-3) and release of an immunodominant epitope","volume":"31","author":"D'Souza","year":"2006","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.jim.2018.02.002_bb0055","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/j.jpain.2008.12.001","article-title":"Sex, gender, and pain: a review of recent clinical and experimental findings","volume":"10","author":"Fillingim","year":"2009","journal-title":"J. Pain"},{"key":"10.1016\/j.jim.2018.02.002_bb0060","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1002\/jnr.490360409","article-title":"Gelatinase B is present in the cerebrospinal fluid during experimental autoimmune encephalomyelitis and cleaves myelin basic protein","volume":"36","author":"Gijbels","year":"1993","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.jim.2018.02.002_bb0065","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jaut.2006.12.004","article-title":"Gender as risk factor for autoimmune diseases","volume":"28","author":"Gleicher","year":"2007","journal-title":"J. Autoimmun."},{"key":"10.1016\/j.jim.2018.02.002_bb0070","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1016\/j.autrev.2016.02.011","article-title":"Autoantibody pain","volume":"15","author":"Goebel","year":"2016","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.jim.2018.02.002_bb0075","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1111\/jnc.12195","article-title":"Myelin management by the 18.5-kDa and 21.5-kDa classic myelin basic protein isoforms","volume":"125","author":"Harauz","year":"2013","journal-title":"J. Neurochem."},{"key":"10.1016\/j.jim.2018.02.002_bb0080","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/j.micron.2004.04.005","article-title":"Myelin basic protein-diverse conformational states of an intrinsically unstructured protein and its roles in myelin assembly and multiple sclerosis","volume":"35","author":"Harauz","year":"2004","journal-title":"Micron"},{"key":"10.1016\/j.jim.2018.02.002_bb0085","doi-asserted-by":"crossref","first-page":"e451","DOI":"10.1111\/j.1365-2567.2008.02999.x","article-title":"Autoantibodies to myelin basic protein (MBP) in healthy individuals and in patients with multiple sclerosis: a role in regulating cytokine responses to MBP","volume":"128","author":"Hedegaard","year":"2009","journal-title":"Immunology"},{"key":"10.1016\/j.jim.2018.02.002_bb0090","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/j.bbi.2016.11.003","article-title":"Reciprocal relationship between membrane type 1 matrix metalloproteinase and the algesic peptides of myelin basic protein contributes to chronic neuropathic pain","volume":"60","author":"Hong","year":"2017","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.jim.2018.02.002_bb0095","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1006\/clin.1997.4412","article-title":"Epidemiology and estimated population burden of selected autoimmune diseases in the United States","volume":"84","author":"Jacobson","year":"1997","journal-title":"Clin. Immunol. Immunopathol."},{"key":"10.1016\/j.jim.2018.02.002_bb0100","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1002\/eji.1830210323","article-title":"Chronic experimental autoimmune encephalomyelitis induced by the 89-101 myelin basic protein peptide in B10RIII (H-2r) mice","volume":"21","author":"Jansson","year":"1991","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.jim.2018.02.002_bb0105","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1038\/277140a0","article-title":"Identification of the neuritogen for experimental allergic neuritis","volume":"277","author":"Kadlubowski","year":"1979","journal-title":"Nature"},{"key":"10.1016\/j.jim.2018.02.002_bb0110","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1053\/eujp.2001.0307","article-title":"Morphine responsiveness in a group of well-defined multiple sclerosis patients: a study with i.v. morphine","volume":"6","author":"Kalman","year":"2002","journal-title":"Eur. J. Pain"},{"key":"10.1016\/j.jim.2018.02.002_bb0115","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.brainres.2011.06.022","article-title":"Detailed characterization of neuro-immune responses following neuropathic injury in mice","volume":"1405","author":"Kim","year":"2011","journal-title":"Brain Res."},{"key":"10.1016\/j.jim.2018.02.002_bb0120","article-title":"The MMP-9\/TIMP-1 axis controls the status of differentiation and function of myelin-forming Schwann cells in nerve regeneration","volume":"7","author":"Kim","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.jim.2018.02.002_bb0125","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1212\/WNL.0b013e3182698cab","article-title":"Chronic pain as a manifestation of potassium channel-complex autoimmunity","volume":"79","author":"Klein","year":"2012","journal-title":"Neurology"},{"key":"10.1016\/j.jim.2018.02.002_bb0130","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1016\/j.bbi.2016.03.003","article-title":"Spinal activity of interleukin 6 mediates myelin basic protein-induced allodynia","volume":"56","author":"Ko","year":"2016","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.jim.2018.02.002_bb0135","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1016\/j.mcn.2008.08.008","article-title":"MMPs initiate Schwann cell-mediated MBP degradation and mechanical nociception after nerve damage","volume":"39","author":"Kobayashi","year":"2008","journal-title":"Mol. Cell. Neurosci."},{"key":"10.1016\/j.jim.2018.02.002_bb0140","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.jneuroim.2010.08.007","article-title":"T cells that trigger acute experimental autoimmune encephalomyelitis also mediate subsequent disease relapses and predominantly produce IL-17","volume":"230","author":"Li","year":"2011","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.jim.2018.02.002_bb0145","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1038\/nm1402","article-title":"Neuron-mediated generation of regulatory T cells from encephalitogenic T cells suppresses EAE","volume":"12","author":"Liu","year":"2006","journal-title":"Nat. Med."},{"key":"10.1016\/j.jim.2018.02.002_bb0150","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1186\/1742-2094-9-119","article-title":"Immunodominant fragments of myelin basic protein initiate T cell-dependent pain","volume":"9","author":"Liu","year":"2012","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.jim.2018.02.002_bb0155","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1038\/nrn3946","article-title":"Crosstalk between the nociceptive and immune systems in host defence and disease","volume":"16","author":"McMahon","year":"2015","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.jim.2018.02.002_bb0160","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1002\/jnr.23844","article-title":"Pain in autoimmune disorders","volume":"95","author":"Mifflin","year":"2017","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.jim.2018.02.002_bb0165","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1016\/j.jpain.2015.05.002","article-title":"Estimates of pain prevalence and severity in adults: United States, 2012","volume":"16","author":"Nahin","year":"2015","journal-title":"J. Pain"},{"key":"10.1016\/j.jim.2018.02.002_bb0170","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/S0165-5728(03)00002-X","article-title":"Myelin basic protein-reactive autoantibodies in the serum and cerebrospinal fluid of multiple sclerosis patients are characterized by low-affinity interactions","volume":"136","author":"O'Connor","year":"2003","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.jim.2018.02.002_bb0175","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1007\/s40122-013-0016-9","article-title":"Management of fibromyalgia syndrome: review of evidence","volume":"2","author":"Okifuji","year":"2013","journal-title":"Pain Ther."},{"key":"10.1016\/j.jim.2018.02.002_bb0180","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.jneuroim.2015.07.004","article-title":"Effects of active immunisation with myelin basic protein and myelin-derived altered peptide ligand on pain hypersensitivity and neuroinflammation","volume":"286","author":"Perera","year":"2015","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.jim.2018.02.002_bb0185","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1186\/s12974-015-0253-4","article-title":"Active immunization with myelin-derived altered peptide ligand reduces mechanical pain hypersensitivity following peripheral nerve injury","volume":"12","author":"Perera","year":"2015","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.jim.2018.02.002_bb0190","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1136\/jnnp.2006.089839","article-title":"Anti-myelin antibodies in multiple sclerosis: clinically useful?","volume":"77","author":"Polman","year":"2006","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.jim.2018.02.002_bb0195","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1002\/ana.22366","article-title":"Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria","volume":"69","author":"Polman","year":"2011","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.jim.2018.02.002_bb0200","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1006\/bbrc.1993.1540","article-title":"Leukocyte gelatinase B cleavage releases encephalitogens from human myelin basic protein","volume":"192","author":"Proost","year":"1993","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.jim.2018.02.002_bb0205","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.jim.2011.10.010","article-title":"An enzyme-linked immunosorbent assay (ELISA) for quantification of human collectin 11 (CL-11, CL-K1)","volume":"375","author":"Selman","year":"2012","journal-title":"J. Immunol. Methods"},{"key":"10.1016\/j.jim.2018.02.002_bb0210","doi-asserted-by":"crossref","first-page":"30615","DOI":"10.1074\/jbc.M109.041244","article-title":"Inflammatory proprotein convertase-matrix metalloproteinase proteolytic pathway in antigen-presenting cells as a step to autoimmune multiple sclerosis","volume":"284","author":"Shiryaev","year":"2009","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jim.2018.02.002_bb0215","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0004952","article-title":"Matrix metalloproteinase proteolysis of the myelin basic protein isoforms is a source of immunogenic peptides in autoimmune multiple sclerosis","volume":"4","author":"Shiryaev","year":"2009","journal-title":"PLoS One"},{"key":"10.1016\/j.jim.2018.02.002_bb0220","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/S0006-8993(99)02321-5","article-title":"Upregulation and interaction of TNFalpha and gelatinases A and B in painful peripheral nerve injury","volume":"855","author":"Shubayev","year":"2000","journal-title":"Brain Res."},{"key":"10.1016\/j.jim.2018.02.002_bb0225","doi-asserted-by":"crossref","first-page":"890","DOI":"10.4103\/1673-5374.184452","article-title":"Role of myelin auto-antigens in pain: a female connection","volume":"11","author":"Shubayev","year":"2016","journal-title":"Neural Regen. Res."},{"key":"10.1016\/j.jim.2018.02.002_bb0230","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.neuroscience.2016.06.006","article-title":"Neurobiology of fibromyalgia and chronic widespread pain","volume":"338","author":"Sluka","year":"2016","journal-title":"Neuroscience"},{"key":"10.1016\/j.jim.2018.02.002_bb0235","first-page":"1245","article-title":"Pharmacological management of pain in patients with multiple sclerosis","volume":"70","author":"Solaro","year":"2010","journal-title":"Drugs"},{"key":"10.1016\/j.jim.2018.02.002_bb0240","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/S0006-8993(01)03408-4","article-title":"Antibody directed against GD(2) produces mechanical allodynia, but not thermal hyperalgesia when administered systemically or intrathecally despite its dependence on capsaicin sensitive afferents","volume":"930","author":"Sorkin","year":"2002","journal-title":"Brain Res."},{"key":"10.1016\/j.jim.2018.02.002_bb0245","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1186\/s13028-014-0055-1","article-title":"Validation of an enzyme-linked immunosorbent assay developed for measuring cortisol concentration in human saliva and serum for its applicability to analyze cortisol in pig saliva","volume":"56","author":"Thomsson","year":"2014","journal-title":"Acta Vet. Scand."},{"key":"10.1016\/j.jim.2018.02.002_bb0250","doi-asserted-by":"crossref","first-page":"168","DOI":"10.3389\/fneur.2013.00168","article-title":"Effects of vaccination with altered peptide ligand on chronic pain in experimental autoimmune encephalomyelitis, an animal model of multiple sclerosis","volume":"4","author":"Tian","year":"2013","journal-title":"Front. Neurol."},{"key":"10.1016\/j.jim.2018.02.002_bb0255","doi-asserted-by":"crossref","first-page":"2355","DOI":"10.1517\/14656566.2011.607162","article-title":"Treating pain in multiple sclerosis","volume":"12","author":"Truini","year":"2011","journal-title":"Expert. Opin. Pharmacother."},{"key":"10.1016\/j.jim.2018.02.002_bb0260","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0138024","article-title":"The prevalence and characteristics of fibromyalgia in the 2012 National Health Interview Survey","volume":"10","author":"Walitt","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.jim.2018.02.002_bb0265","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1136\/annrheumdis-2015-208094","article-title":"Autoantibodies to citrullinated proteins induce joint pain independent of inflammation via a chemokine-dependent mechanism","volume":"75","author":"Wigerblad","year":"2016","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.jim.2018.02.002_bb0270","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1002\/art.1780330203","article-title":"The American College of Rheumatology 1990 criteria for the classification of fibromyalgia. Report of the multicenter criteria committee","volume":"33","author":"Wolfe","year":"1990","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.jim.2018.02.002_bb0275","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1002\/acr.20140","article-title":"The American College of Rheumatology preliminary diagnostic criteria for fibromyalgia and measurement of symptom severity","volume":"62","author":"Wolfe","year":"2010","journal-title":"Arthritis Care Res."},{"key":"10.1016\/j.jim.2018.02.002_bb0280","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/j.autrev.2006.10.001","article-title":"Gender and autoimmunity","volume":"6","author":"Zandman-Goddard","year":"2007","journal-title":"Autoimmun. Rev."}],"container-title":["Journal of Immunological Methods"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022175917305094?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022175917305094?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,19]],"date-time":"2025-09-19T16:33:47Z","timestamp":1758299627000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022175917305094"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,4]]},"references-count":56,"alternative-id":["S0022175917305094"],"URL":"https:\/\/doi.org\/10.1016\/j.jim.2018.02.002","relation":{},"ISSN":["0022-1759"],"issn-type":[{"value":"0022-1759","type":"print"}],"subject":[],"published":{"date-parts":[[2018,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A sensitive and selective ELISA methodology quantifies a demyelination marker in experimental and clinical samples","name":"articletitle","label":"Article Title"},{"value":"Journal of Immunological Methods","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jim.2018.02.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}